MedTrace Logo

Diabetes Mellitus and Vulvovaginal Candidiasis

NCT00353561 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2008-05-22

No results posted yet for this study

Summary

Clinical and mycological response to oral fluconazole and boric acid suppositories was assessed in patients with diabetes mellitus and vulvovaginal candidiasis.

Conditions

Interventions

DRUG

Boric

Gelatin capsules filled with 600 mg of boric acid

DRUG

Fluconazole

150 mg oral fluconazole gives once in 14 days

Sponsors & Collaborators

  • Indian Council of Medical Research

    lead OTHER_GOV

Principal Investigators

  • Ravinder Goswami, DM · All India Institute of Medical Sciences New Delhi, 110029, India

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
66 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-06-30
Primary Completion
2006-04-30
Completion
2006-04-30

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00353561 on ClinicalTrials.gov